CLASS II Drug recall · Reported 6 Dec 2017 · FDA Enforcement Report
Clozapine Tablets USP, 100 mg recalled by Teva Pharmaceuticals U
Teva Pharmaceuticals U is recalling Clozapine Tablets USP, 100 mg, distributed nationwide in the US. The recall was initiated on 9 Nov 2017 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0096-2018
- FDA event ID
- 78552
- Recalling firm
- Teva Pharmaceuticals U, North Wales, PA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 9 Nov 2017
- FDA classified
- 27 Nov 2017
- Reported
- 6 Dec 2017
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
Timeline
| 9 Nov 2017 | Recall initiated by company | |
| 27 Nov 2017 | Classified by FDA | +18 days |
| 6 Dec 2017 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Failed Tablet/Capsule Specifications; potential presence of broken tablets.
Product as listed by the FDA
Clozapine Tablets USP, 100 mg, 500 count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICALS IND, LTD, Jerusalem Israel, Manufactured For: TEVA PHARMACEUTICALS USA, North Wales, PA, NDC 00093-7772-05
Where it was distributed
Nationwide
Questions about this recall
Is Clozapine Tablets USP, 100 mg recalled?
Yes. Teva Pharmaceuticals U recalled Clozapine Tablets USP, 100 mg on 9 Nov 2017. The recall is Class II and its status is Terminated. Recall number D-0096-2018.
Why was it recalled?
Failed Tablet/Capsule Specifications; potential presence of broken tablets.
Which lots are affected?
Lot # 39C192, exp 06/2019
Where was it sold?
Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Teva Pharmaceuticals U
All 196| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Tretinoin Capsules, 10 mg recalled by Teva Pharmaceuticals U | Teva Pharmaceuticals U | Potency & Assay | Nationwide |
| Drug | CLASS II | Doxylamine Succinate and Pyridoxine Hydrochloride recalledDoxylamine Succinate And Pyridoxine Hydrochloride | Teva Pharmaceuticals U | Potency & Assay | Nationwide |
| Drug | CLASS III | Mimvey (estradiol and norethindrone acetate tablets USP) recalledMimvey | Teva Pharmaceuticals U | Labeling Errors | Nationwide |
| Drug | CLASS III | Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg recalledMimvey | Teva Pharmaceuticals U | Labeling Errors | Nationwide |
| Drug | CLASS II | Brinzolamide Ophthalmic Suspension recalled by Teva Pharmaceuticals U | Teva Pharmaceuticals U | Packaging Defects | Nationwide |
Other Clozapine recalls
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Clozapine Tablets USP tablet, 100mg recalled by Aurobindo Pharma USAClozapine | Aurobindo Pharma USA | Other | Nationwide |
| Drug | CLASS II | Clozapine Orally Disintegrating Tablets, 5 mg recalledClozapine | Teva Pharmaceuticals U | Potency & Assay | Nationwide |
| Drug | CLASS II | Clozapine Tablets USP, 25 mg bottle recalled by Teva Pharmaceuticals U | Teva Pharmaceuticals U | Sterility | Nationwide |